Allogeneic transplant in patients ≥60 years of age with first relapsed or refractory acute myeloid leukemia after treatment with vosaroxin or placebo plus cytarabine: Results from VALOR Meeting Abstract
| Authors: | Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Erba, H. P.; Pigneux, A.; Horst, H. A.; Recher, C.; Klimek, V. M.; Odenike, O.; Craig, A. R.; Ward, R.; Smith, J. A.; Kantarjian, H. M.; Stuart, R. K.; Schiller, G. J. |
| Abstract Title: | Allogeneic transplant in patients ≥60 years of age with first relapsed or refractory acute myeloid leukemia after treatment with vosaroxin or placebo plus cytarabine: Results from VALOR |
| Meeting Title: | 20th Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 100 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Jun 11-14 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2015-06-01 |
| Start Page: | 42 |
| Language: | English |
| ACCESSION: | WOS:000361204901087 |
| PROVIDER: | wos |
| PMCID: | PMC4480587 |
| Notes: | Meeting Abstract: P187 -- Source: Wos |
MSK Authors
-
147Klimek